The Pfizer BioNTech vaccine has been approved for children over the age of 12 in Australia. The Therapeutic Goods Administration has approved the jab for young teenagers and is currently in the process of determining when they will get their turn. The TGA also stated that the decision was made on the basis of short term efficacy and safety data. ‘Continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials’ it said in a statement.
With over-16-year-olds already provisionally approved for the vaccine, the TGA has still been undertaking research into the effects of the jab on youth. Despite the approval for 12-year-olds and over, the age group is not set to receive the jab for a while as the general population still needs to get its turn. Vulnerable children will be given priority however, as revealed by the Australian Federal government.
#MaltaDaily
Photo Source: LiveScience, Logos Download